Literature DB >> 3242527

Histopathologic and biochemical analysis of classic Pelizaeus-Merzbacher disease.

K Iyoda1, J Tanaka, Y Suzuki, Y Nagao, S Ohtahara.   

Abstract

An autopsy study of an 11-year-old boy with the classic type of Pelizaeus-Merzbacher disease is presented. He developed normally until 5 years of age when he began to deteriorate with scanning speech and gait abnormality. Auditory brainstem responses were normally preserved. At the age of 11 years, 8 months, he died of pneumonia while in a vegetative state. The neuropathologic findings suggested a typical classic type of Pelizaeus-Merzbacher disease and biochemical analysis of cerebral white matter demonstrated a decreased ratio of long-chain fatty acids (greater than or equal to C19) to short- and medium-chain fatty acids (less than C19). These findings suggested defective myelin synthesis as the etiology of Pelizaeus-Merzbacher disease; comprehensive classifications of the disease are expected to include both pathologic and biochemical parameters.

Entities:  

Mesh:

Year:  1988        PMID: 3242527     DOI: 10.1016/0887-8994(88)90041-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  Pelizaeus-Merzbacher disease.

Authors:  R Kumar; S Aneja; V Taluja; A Agarwal; H Mahajan
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

2.  Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.

Authors:  Jeremy J Laukka; John Kamholz; Denise Bessert; Robert P Skoff
Journal:  Neurosci Lett       Date:  2016-05-17       Impact factor: 3.046

3.  Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease.

Authors:  Sina K Stumpf; Stefan A Berghoff; Andrea Trevisiol; Lena Spieth; Tim Düking; Lennart V Schneider; Lennart Schlaphoff; Steffi Dreha-Kulaczewski; Annette Bley; Dinah Burfeind; Kathrin Kusch; Miso Mitkovski; Torben Ruhwedel; Philipp Guder; Heiko Röhse; Jonas Denecke; Jutta Gärtner; Wiebke Möbius; Klaus-Armin Nave; Gesine Saher
Journal:  Acta Neuropathol       Date:  2019-03-27       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.